Assessment of Tamoxifen-Related Endometrial Changes in Premenopausal Female Patients With Diffusion-Weighted Magnetic Resonance Imaging.

PURPOSE To evaluate tamoxifen-related endometrial changes in premenopausal female patients with diffusion-weighted magnetic resonance imaging (DWI). METHODS This prospective study was performed on 71 premenopausal female patients (mean age, 41 years) who were receiving tamoxifen therapy. All patients underwent magnetic resonance imaging with DWI of the pelvis and hysteroscopic-guided endometrial biopsy. The apparent diffusion coefficient (ADC) values of the endometrial plate were calculated and correlated with pathological results. RESULTS The mean ADCs of tamoxifen-related benign endometrial lesions (1.35 ± 0.19 and 1.32 ± 0.13 × 10 mm/s) were significantly higher (P = 0.001) than those of normal endometrial plate (0.95 ± 0.11 and 0.93 ± 0.11 × 10 mm/s) by both reviewers, respectively. The cutoff ADC values used to differentiate tamoxifen-related benign endometrial lesions from normal endometrium were 1.07 and 1.02 × 10 mm/s with areas under the curve of 0.94 and 0.93 and accuracy of 94.4 and 95.8 by both reviewers, respectively. The mean ADC values of endometrial polyp (EP) (1.44 ± 0.19 and 1.42 ± 0.22 × 10 mm/s) were significantly higher (P = 0.001) than those of endometrial hyperplasia (EH) (1.25 ± 0.19 and 1.23 ± 0.19 × 10 mm/s) by both reviewers, respectively. The cutoff ADC values used to differentiate EP from EH were 1.38 × 10 and 1.36 × 10 mm/s with areas under the curve of 0.81 and 0.77 and accuracy of 80% and 70% by both reviewers, respectively. There was an insignificant difference in ADC value between typical and atypical EH. The ADC values of endometrial cancer (0.80 and 0.78 × 10 mm/s) were lower than those of tamoxifen-related benign endometrial lesions. The final diagnosis was normal endometrium (n = 36), benign endometrial lesions either EH (n = 17), or EP (n = 16), and endometrial cancer in only 2 patients. CONCLUSIONS We concluded that DWI helps in detection and characterization of different tamoxifen-related endometrial changes in the premenopausal female patients.

[1]  Z. Vaknin,et al.  Prediction of Premalignant and Malignant Endometrial Polyps by Clinical and Hysteroscopic Features. , 2019, Journal of minimally invasive gynecology.

[2]  A. Razek.  Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors. , 2019, Magnetic resonance imaging.

[3]  Gada Gaballa,et al.  Clinical Applications of Arterial Spin Labeling in Brain Tumors. , 2019, Journal of computer assisted tomography.

[4]  J. Prat,et al.  A proposal for updating the staging of endometrial cancer , 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  C. Quick,et al.  Benign and Premalignant Lesions of the Endometrium. , 2019, Surgical pathology clinics.

[6]  R. Markham,et al.  Endometrial polyps: Pathogenesis, sequelae and treatment , 2019, SAGE open medicine.

[7]  L. Insabato,et al.  Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria , 2019, Histopathology.

[8]  L. Insabato,et al.  Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis , 2019, Archives of Gynecology and Obstetrics.

[9]  O. Nikolic,et al.  Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers , 2019, Insights into Imaging.

[10]  A. A. Abdel Razek,et al.  Diffusion tensor imaging parameters in differentiation recurrent breast cancer from post-operative changes in patients with breast-conserving surgery. , 2019, European journal of radiology.

[11]  N. Teixeira,et al.  Uterine histopathological changes induced by acute administration of tamoxifen and its modulation by sex steroid hormones , 2019, Toxicology and applied pharmacology.

[12]  I. B. Gultekin,et al.  Elastosonographic evaluation of endometrium in women using tamoxifen for breast cancer , 2019, Nigerian journal of clinical practice.

[13]  K. Ng,et al.  Current Status of Magnetic Resonance Imaging in Patients with Malignant Uterine Neoplasms: A Review , 2018, Korean journal of radiology.

[14]  Guofu Zhang,et al.  The ability of ADC measurements in the assessment of patients with stage I endometrial carcinoma based on three risk categories , 2019, Acta radiologica.

[15]  D. Hippe,et al.  Diagnosing Polyps on Transvaginal Sonography: Is Sonohysterography Always Necessary? , 2018, Ultrasound quarterly.

[16]  G. Israel,et al.  Magnetic Resonance Imaging Features of Endometrial Polyps: Frequency of Occurrence and Interobserver Reliability , 2018, Journal of computer assisted tomography.

[17]  E. Sala,et al.  Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology , 2018, European Radiology.

[18]  N. Yu,et al.  The utility of measuring the apparent diffusion coefficient for peritumoral zone in assessing infiltration depth of endometrial cancer , 2018, Cancer Imaging.

[19]  A. Razek.  Routine and Advanced Diffusion Imaging Modules of the Salivary Glands , 2018 .

[20]  A. A. Abdel Razek,et al.  Routine and Advanced Diffusion Imaging Modules of the Salivary Glands. , 2018, Neuroimaging clinics of North America.

[21]  Mohamed Abdelsalam,et al.  Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics , 2018, Neuroradiology.

[22]  Yan Li,et al.  Quantitative evaluation of diffusion-kurtosis imaging for grading endometrial carcinoma: a comparative study with diffusion-weighted imaging. , 2017, Clinical radiology.

[23]  H. Addley,et al.  Diffusion-weighted imaging in gynaecological malignancy. , 2017, Clinical radiology.

[24]  I. Petkovska,et al.  Benign Gynecologic Conditions of the Uterus. , 2017, Magnetic resonance imaging clinics of North America.

[25]  M. Tatsumi,et al.  Preoperative staging of endometrial cancer using reduced field-of-view diffusion-weighted imaging: a preliminary study , 2017, European Radiology.

[26]  Baris Bakir,et al.  Role of diffusion weighted MRI in the differential diagnosis of endometrial cancer, polyp, hyperplasia, and physiological thickening. , 2017, Clinical imaging.

[27]  A. Razek,et al.  Diffusion tensor imaging of mild-moderate carpal tunnel syndrome: correlation with nerve conduction study and clinical tests , 2017, Clinical Rheumatology.

[28]  A. A. Abdel Razek,et al.  Assessment of diffusion tensor imaging metrics in differentiating low-grade from high-grade gliomas , 2016, The neuroradiology journal.

[29]  A. Razek,et al.  Correlation of Choline/Creatine and Apparent Diffusion Coefficient values with the prognostic parameters of Head and Neck Squamous Cell Carcinoma , 2016, NMR in biomedicine.

[30]  A. Razek,et al.  Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging , 2016, Breast Cancer.

[31]  S. Tirumani,et al.  Comparison of ADC values in different malignancies of the skeletal musculature: a multicentric analysis , 2015, Skeletal Radiology.

[32]  A. Rockall,et al.  MRI appearances of benign uterine disease. , 2014, Clinical radiology.

[33]  A. A. Abdel Razek,et al.  Nasopharyngeal carcinoma: correlation of apparent diffusion coefficient value with prognostic parameters , 2013, La radiologia medica.

[34]  A. A. Abdel Razek,et al.  Apparent diffusion coefficient values of mediastinal masses in children. , 2012, European journal of radiology.

[35]  A. Razek,et al.  Correlation of Apparent Diffusion Coefficient at 3T with Prognostic Parameters of Retinoblastoma , 2012, American Journal of Neuroradiology.

[36]  A. Razek,et al.  Role of Perfusion Magnetic Resonance Imaging in Cervical Lymphadenopathy , 2011, Journal of computer assisted tomography.

[37]  A. Razek,et al.  Role of diffusion-weighted MR imaging in assessing malignant versus benign skull-base lesions , 2011, La radiologia medica.

[38]  H. Boezen,et al.  Effect of Tamoxifen on the Endometrium and the Menstrual Cycle of Premenopausal Breast Cancer Patients , 2009, International Journal of Gynecologic Cancer.

[39]  S. Ascher,et al.  The effect of tamoxifen on the genital tract , 2008, Cancer imaging : the official publication of the International Cancer Imaging Society.

[40]  S. Ascher,et al.  Tamoxifen-induced uterine abnormalities: the role of imaging. , 2000, Radiology.